Status:
COMPLETED
Serum Neuroglobin and Nogo-A Concentrations in Acute Traumatic Brain Injury
Lead Sponsor:
Shanghai 6th People's Hospital
Conditions:
Traumatic Brain Injury
Eligibility:
All Genders
18-80 years
Brief Summary
Neuroglobin has been described as a marker of traumatic brain injury. Nogo-A plays an important role in mediating neuroanatomical plasticity and functional recovery following traumatic brain injury. T...
Eligibility Criteria
Inclusion
- Patients who suffered head trauma and whose highest abbreviated injury score (AIS) was 3 or less (other than head injury)
- Patients who delivered to hospital within 4 h
Exclusion
- Patients who suffered open injuries
- Patients who had existing prior neurological disease
- Patients whose serial serum samples could not be obtained
- Patients less than 18 years of age
- Patients who suffered severe life-threatening injury to organs other than the brain
Key Trial Info
Start Date :
May 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT02229643
Start Date
May 1 2012
End Date
June 1 2014
Last Update
August 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Sixth People's Hospital
Shanghai, China, 200233